Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L4BR
|
||||
Former ID |
DIB010253
|
||||
Drug Name |
HuCD40L
|
||||
Synonyms |
Avrend; CD40 ligand, Celldex; CD40 ligand, Immunex; HuCD40L, Immunex
|
||||
Company |
Amgen
|
||||
Target and Pathway | |||||
Target(s) | Tumor necrosisfactor receptor superfamily member 5 | Target Info | Binder | [525648] | |
KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
NF-kappa B signaling pathway | |||||
Cell adhesion molecules (CAMs) | |||||
Toll-like receptor signaling pathway | |||||
Intestinal immune network for IgA production | |||||
Malaria | |||||
Toxoplasmosis | |||||
HTLV-I infection | |||||
Epstein-Barr virus infection | |||||
Transcriptional misregulation in cancer | |||||
Asthma | |||||
Autoimmune thyroid disease | |||||
Systemic lupus erythematosus | |||||
Allograft rejection | |||||
Primary immunodeficiency | |||||
Viral myocarditis | |||||
Pathway Interaction Database | CD40/CD40L signaling | ||||
References | |||||
Ref 468148 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5077). | ||||
Ref 546452 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008196) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.